enVVeno (NVNO) Stock Rallies After Release of Encouraging Interim Results
enVVeno Medical Corporation (NASDAQ: NVNO) saw its stock price surge by 17.83%, reaching $4.10 at last check, after unveiling compelling interim data from its pivotal VenoValve clinical trial. The findings are being formally reported at the Society for Vascular Surgery’s 2025 Vascular Annual Meeting (VAM25) taking place in New Orleans, Louisiana, from June 4–7. VenoValve […]